Dr. Christopher P. Tardif, MD

Dr. Tardif practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Dr. Tardif's NPI, 1528096708, was assigned on June 28, 2006. Dr. Tardif graduated from University of North Carolina School of Medicine in 1989. Dr. Tardif holds Florida license ME67894.

Dr. Tardif's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Tardif's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Dr. Tardif is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Tardif to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tardif practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tardif's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Tardif is board certified in urology by the American Board of Urology. Dmand AI has Dr. Tardif's licenses on file in 4 states: Florida, Kansas, District of Columbia and Maryland.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Tardif treats.

CMS data shows 2,049 Medicare services from Dr. Tardif across 16 procedure codes in 2024, for 949 Medicare patients. Medicare paid $140,697 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 949 Medicare patients who saw Dr. Tardif in 2024. The largest group is 75 to 84, with 429 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tardif's median patient age at 73, with 24% women.

In 2024, Dr. Tardif wrote 3,104 Medicare Part D claims for 930 patients. 96% of them were for generic drugs. CMS names the drug for 3,019 of them, across 29 drugs with 11 or more claims each, at $94,269 in total drug cost. In 2023, CMS named 3,044 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Tardif for performance year 2024, reported through an alternative payment model (APM). Dr. Tardif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of prostate resection by Dr. Tardif, more than 79% of the clinicians it reports for that procedure.

CMS Open Payments shows 8 general payments to Dr. Tardif from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 82% of the total. PROCEPT BioRobotics Corporation paid the most, $287.

Dmand AI lists 2 awards for Dr. Tardif, most recently CMS Stage 1 EHR in 2013.

Dr. Tardif graduated from University of North Carolina School of Medicine in 1989. Dr. Tardif is a member of ACS.

Dr. Tardif is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.